The FDA has approved on 17 My 2012 generic versions of Plavix (clopidogrel) for Dr Reddy's Laboratories, Gate Pharmaceuticals, Mylan...
Mylan and Biocon, announced on 28 April 2020 the launch of their pegfilgrastim biosimilar, Fulphila, in Canada. This is the second biosimilar from the pair to be launched in the country.
A US District Court in a case brought by Hospira has invalidated four patents extending to 2020 for Cubicin (daptomycin)from...
The FDA has approved the first generic versions of Singulair (montelukast sodium)from AstraZeneca for use in adults and children to...
Teva Pharmaceutical Industries announced that it has withdrawn its cash and stock proposal to acquire all of the outstanding ordinary...
Mylan N.V. announced that it has officially commenced its formal offer to acquire all outstanding ordinary shares of Perrigo Company...
Teva Pharmaceutical Industries Ltd. announced a proposal to acquire all of the outstanding shares of Mylan N.V. in a transaction...
Mylan N.V. and Biocon Ltd. announced that the FDA has accepted Mylan's biologics license application (BLA) for MYL 1401O, (Hertraz)...
The Board of Directors of Meda AB hereby confirms that it has been contacted by Mylan, Inc.regarding an indicative proposal...
Mylan N.V. announced that Mylan has made a proposal to acquire Perrigo Company plc in a cash-and-stock transaction that would...